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Debate on the use of SI units in clinical chemistry has
continued for many years. Despite the recommendations
made by the International Union of Pure and Applied
Chemistry (IUPAC) and the International Federation of
Clinical Chemistry (IFCC) in 1967 [1] and 1979 [2], and
the World Health Organization (WHO) in 1977 [3], to
use molar units to report clinical laboratory data, many
countries have not yet made a commitment to do this.
However, the situation may change in the near future:
Australia, Scandinavia and the United Kingdom have
been largely committed to the recommended SI units,
with a variablecommitment in the remainder of Europe,
ranging from virtually 100% in Switzerland to 20% in
Italy and 5% in Germany. Canada converted in 1982 and
the USA plans to do so in the future [4]. The manufacture
and marketing of equipment and reagents is largely
directed at these countries, which will make it increas-
ingly difficult for those who have not changed, like most of
Latin America and Asia, to communicate on scientific
matters relating to their patients.
which may be used singly, or in combinations, to describe
most quantitative measurements. The combinations are
the derived units which are algebraic expressions of the
base units using mathematical operations. In addition,
there are units in common usage which are not part of SI
but are recognized by the CGPM because of their
accepted universal usage, for instance the minute (min),
hour (h), day (d), and litre (1). Of particular importance
is the litre, which has been agreed as the fundamental
unit of volume in clinical chemistry [1]. The designated
symbol for the litre is or L. The upper-case L has the
advantage that it cannot be confused with the number
one in typescript, and is now required for manyjournals.
(In the UK and USA the use of L is an official
recommendation.) For these reasons, L is used in this
article. To permit a wide range of magnitude of
quantitative measurement, the SI includes a set of
prefixes to the units that is added to denote an increase or
decrease in the order of magnitude of the quantity
rangingfrom 1018 to 10-18. In clinical chemistrychanges in
orders of magnitude of 102, ae recommended [1],
although prefixes for 10
-2 10- 10 and 10 are an
accepted part of SI.
For these reasons, it is appropriate to reiterate the
recommendations made by IUPAC and IFCC [2], to
present some data on conversion factors and to offer
guidance on procedures for conversion. Arguments for and against the adoption of the mole
Syst6me International d’Unit6s
The Systme International d’Unitds (SI) was adopted by
the General Conference of Weights and Measures
(CGPM) in 1960 and was later accepted in principle by
IUPAC and IFCC. The system defines seven base units
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Mass units and units for amount of substance, the
kilogram and the mole respectively, are both acceptable
within the SI. In clinical chemistry use of the mole is
preferred wherever possible, the main issues ofthe debate
being:
Argurnentsfor:
(1) The mole is scientifically appropriate, as most
methods of analysis (spectroscopy, fluorimetry,
immunoassay etc.) are based on the measurement of
numbers of molecules and not their mass.
(2) The concentration of a calibration standard is
defined unambiguously. It is unaffected by the
chemical form of the material used, for example
glucose standards may be prepared from anhydrous
glucose or glucose monohydrate. A given volume ofa
standard solution, having a concentration of 10
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mmol/L, contains an unambiguous quantity of
C6H1206, whereas a standard of "80 g/L (or 180 mg/
dL) contains differing amounts ofC6H1206, depend-
ing 9n which form of glucose is used in its prep-
aration. This is a particular problem with therapeutic
drug measurements where different salts and conju-
gates of a drug, perhaps with different degrees of
hydration, are available and may be suitable both for
administration to patients and calibration of ana-
lyses. Although pharmaceutical preparations are
usually clearly marked in this respect, there is the
possibility of confusion among medical and para-
medical staff who do not fully appreciate that the
same mass of different forms of the same compound
will probably contain different amounts of the active
component.
(3) Physiological relationships between substances com-
monly occur on a mole-to-mole basis, for example
mole ofhaemoglobin and mole of02 yield mole of
oxyhaemoglobin. This is particularly important with
pharmacological agents where active metabolites
may be present, or different metabolites in the same
metabolic pathway are being measured, for example
lactate and pyruvate. Indeed, the use of molar units
may help in understanding the molecular mecha-
nisms of disease processes more easily.
(4) At the present time, many different units are used to
express the concentration of some analytes (for
example mmol/L, meq/L, mg/L, mg/dL for plasma
calcium), which can lead to misunderstanding and
misinterpretation.
(5) As more countries adopt the recommended SI units,
it is going to become more difficult for the remaining
countries not to do so. Increasingly, manufacturers
and journals are going to use these units or require
them to be used.
(6) There is, therefore, a strong argument for uniformity.
This is particularly true in the field of therapeutic
drug monitoring, where, for example, up to seven
different units have been reported for measuring
digoxin [5]. The same problem arises with many
hormone assays, such as thyroxine [6].
Arguments against:
(1) The change to the mole has not been universally
popular with clinicians in those countries where
reporting in molar units has been implemented.
Some do not see the need for change and are
concerned about, the risks of clinical misinterpreta-
tion as a result.
(2) In clinical chemistry laboratories balances are used
to measure the quantity of materials for standards
and calibrants in mass units. Consequently, there are
risks that solutions may be prepared incorrectly if
molar units are used instead.
(3) The reference and/or pathological range for some
analytes are cumbersome, for example urate is
expressed to three figures (ptmol/L), or to three places
of decimals (mmol/L), calcium to two places of
decimals (mmol/L).
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(4) Substances which are administered to patients and
are subsequently measured in plasma, serum etc, are
prescribed in mass units and should therefore be
measured in the same units.
Conclusions
The strongest argument against the use of the mole is the
one which suggests that confusion will be caused by the
change. This is an argument against change and not SI
units per se. If there was uniformity, this would be the
strongest argument ofall, but as there is not, the strongest
argument for change is the one towards uniformity, to
avoid the risk of confusion and misunderstanding that
exists at present. If the need for uniformity is accepted,
then the mole is the most scientifically acceptable unit.
Against this, the other points of the argument are
insignificant. If some clinical chemists are unable to
prepare solutions in molar concentrations correctly, their
ability to prepare solutions in mass concentrations must
also be questioned. Some measurements may seem to be
cumbersome in molecular units, but, equally, so are some
in mass units. This will cease to be a problem as
molecular units become more familiar. There is no need
to have cumbersome ranges for analytes, since the
number of significant figures in SI units should be
comparable with the number in traditional units and
reporting increments should be selected so that no greater
precision is implied by the use of SI units. Finally, the
inter- and intra-patient relationship between the drug
administered and measured in the patient’s fluids is so
variable that the need to express these in the same unit
has little or no relevance.
A protocol for conversion to the mole
It must be accepted that the conversion, from one set of
units to another, may produce problems for both
clinicians and laboratory staff, with the risk ofmisunder-
standing and misinterpretation. The following protocol is
suggested in order to avoid, or at least minimize,
difficulties in the conversion:
(1) The complete programme should be detailed in
advance, and must include a timetable with dates
indicating when each step has to be completed.
National, regional and/or local organizing com-
mittees should be appointed to co-ordinate this
programme.
(2) Sufficient time must be allowed for each stage to
ensure that the timetable is maintained, and staffare
adequately prepared.
(3) An agreed changeover date must be decided at the
outset and adhered to. This date should be agreed
nationally, if possible, in order that all laboratories
change at the same time. If this is not practicable,
then regions or areas, such as cities and districts,
should aim to change on the same day.IFCC A protocol for the conversion of clinical laboratory data
(4) The change on the specified day must be absolute.
There should not be a ’run in’ period during which
the old and the new systems are used concurrently.
Laboratory staffshould not offer to convert data back to the
old units, but should be able to assist in the
intrepretation of data presented in the new system.
Timetablefor conversion programme
I is not possible to specify exactly how much time should
be allowed for the total conversion programme, as this
will vary from country to country. However, time must be
allowed to set up national advisory bodies, ’including a
steering committee, as well as the local laboratory
programme. It is difficult to see how all of this can be
achieved in less than two years. The laboratory’s
preparation for conversion must include the following
stages, to which suggested time periods have been
assigned. Many parts of this programme need not
(indeed, should not) run consecutively, as they can be
achieved simultaneously.
(1) Agreement should be reached at an early stage on
which quantities will be changed. This list must be
comprehensive so that additional changes at a later
date will be kept to a minimum. Guidance, if not
complete authority for this should come from the
national steering group. (Three months.)
(2) Development and implementation of an education
and training programme for laboratory staff to
ensure that they understand the purpose of the
change, and that they are able to make the appropri-
ate conversions, and advise clinical staff. (Six
months.)
(3) Development and implementation of an education
and training programme for other health-care
personnel, for example nurses and pharmacists. This
should include seminars conducted by members of
the laboratory staff who can explain the purpose of
the change and respond to questions. (Six months.)
(4) Charts and/or tables of conversion data must be
prepared for all analytes, and be circulated to all
health-care personnel. (Three months.)
(5) Redesigning and ordering of laboratory stationery
etc., and conversion ofanalysers to take into account
new units and reference intervals. (Nine months.)
It is highly desirable that the national steering committee
should produce a document or booklet giving guidance on
these points.
This list, and the subsequent discussion, includes all
those clinical chemical analyses for which there are
WHO-recommended methods 10].
Proteins
Specific protein concentrations should be expressed in
molar units where the relative molecular mass is known.
This may also be preferred for albumin, when its
concentration is being compared with other specific
proteins or compounds bound to it, such as bilirubin. A
’relative molecular mass for albumin of 67 000 has been
used to derive the conversion factor in the table. Serum
total protein concentration is expressed in g/L, as no
relative molecular mass can be assigned to a hetero-
geneous mixture of macromolecules. Albumin concen-
tration may also be expressed in g/L in order to compare
its concentration with that of total protein.
Enzymes
The recommended unit for the measurement of catalytic
activity ofenzymes is the katal (kat) [2], which is defined
as the activity that will convert mole of substrate per
second under defined conditions. However, in most
countries the International Unit (U) is still used, and it is
defined as the activity which will convert micromole of
substrate per minute under defined conditions.
Hydrogen ion
Traditionally, hydrogen ion measurement has been made
in pH units. In the recommended units this would be
changed to nmol/L, the relationship between pH and
hydrogen concentration being:
pH -logl0[H+] where [H+] is expressed in mol/L.
A pathological blood pH range cf 7"8 to 6"8 corresponds
to a hydrogen ion concentration range of 16 to 160 nmol/
L. The use of molecular units clearly demonstrates the
wide range in vivo; this being greater than most of the
commonly measured analytes in whole blood, plasma or
serum. However, the pH scale, which is consistent with
the SI, will continue to be widely used.
Partial pressure ofgases
It is recommended that whole blood partial pressure
measurements (i.e. pO2 and pCO2) should be reported in
kilopascals (kPa), rather than millimetres of mercury
(mmHg).
Conversion data
The following list ofthe more frequently assayed serum or
plasma components shows the conversion factors for the
commonly used unit(s) to the recommended. (This is
usually a conversion from mass to molar units, but not
always.) Additional and more comprehensive listings can
be found elsewhere [7-9].
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Conversionfactorsfor the morefrequently assayed serum or plasma components.
Analyte Old units Conversion (multiplication)
factor (old recommended)
Recommended
unit
Acetaminophen mg/L 0"00661
(Paracetamol)
mg/dL 0.0661
AlbuminS" g/dL 10
149
Bicarbonate meq/L
Bilirubin mg/dL 17"
Calcium meq/L 0"5
mg/dL 0"25
Chloride meq/L
Cholesterol mg/dL 0’0259
Cortisol [zg/dL 27’6
Creatinine mg/dL 88"4
Digoxin ng/mL, tg/L 1"28
zg/dL 12"8
Glucose mg/dL 0"0555
Iron [zg/dL 0’179
Lithium meq/L
Magnesium meq/L 0"5
mg/dL 0.411
Phosphate mg/dL 0"323 (as phosphorus)
Potassium meq/L
Salicylate mg/L 0"00724 (as salicylic acid)
mg/dL 0"0724 (as salicylic acid)
Sodium meq/L
Thyroxine tg/dL 12’9
Total protein g/dL 10
Triglyceride mg/dL 0"0124 (as tripalmitin)
mg/dL 0"0113 (as triolein)
Urate mg/dL 59"5 (as uric acid)
0"0594 (as uric acid)
Urea mg/dL 0"167
(Carbamide)
mg/dL 0"357 (as blood urea nitrogen)
mmol/L
mmol/L
g/L
tmol/L
mmol/L
tmol/L
mmol/L
mmol/L
mmol/L
mmol/L
nmol/L
[zmol/L
nmol/L
nmol/L
mmol/L
tmol/L
mmol/L
mmol/L
mmol/L
mmol/L
mmol/L
mmol/L
mmol/L
mmol/L
nmol/L
g/L
mmol/L
mmol/L
mol/L
mmol/L
mmol/L
mmol/L
See text for explanation of two recommended units being given for albumin.
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